About Practically Strategic

Practically Strategic is written by Reid Adler. It’s a forum to talk about his fascination with “strategy” and “innovation,” and his passion for being intentional about some of the things that matter most. These pages are generally about facilitating the innovation process for research with translational potential, for developing meaningful intellectual property, and for offering tips about working effectively on the job and in life.

Reid advises pharmaceutical and biotechnology companies as well as not-for-profit research enterprises on innovation management programs and policies, biological material transfers, license agreements, data sharing initiatives and IP strategies for specific therapeutic products. His consulting practice focuses on the business side of innovation. And he is also a solo practice attorney, admitted to practice in Maryland, Washington DC and before the US Patent and Trademark Office. He continues to advise clients on life science matters in his current law practice, focusing on developing robust IP portfolios and successful technology transactions.

He has taught courses on innovation management, strategic planning, legal aspects of biotechnology, technology transfer and product commercialization for the Johns Hopkins University, George Washington University Law School and DePaul University Law School.

Want to know a little more?

Reid has been involved with innovation management, intellectual property and technology transactions in the life sciences field for over 30 years. He has a long record of success in developing innovation management programs, sophisticated IP strategies, designing and managing cost-effective patent portfolios and negotiating technology-related agreements. His legal career includes experience as a senior partner of two international law firms, Morrison & Foerster and Morgan Lewis, and as general counsel to a genomics pioneer, the J. Craig Venter Institute.  Most recently, he founded Practical Innovation Strategy, consulting on innovation management and translational research for nonprofit organizations and on IP strategy for a major multinational pharmaceutical company.

He was the founding director of the NIH Office of Technology Transfer, and played a key role in developing policies and model agreements, research integrity guidelines and the Uniform Biological Material Transfer Agreement. He holds a J.D. from the George Washington University Law School. After law school, he clerked for Judge Giles Rich at the U.S. Court of Appeals for the Federal Circuit. Then he was a fellow at the Max Planck Institute for Innovation and Competition Law in Munich, Germany. Reid has testified before Congress on technology transfer, published numerous articles, and speaks regularly at professional conferences.

Reid is devoted to his family — wife, kids and grandkids. And he sings with a men’s a cappella group, the Augmented 8. Reid is usually volunteering with or serving on the boards of various DC area not-for-profits involved with education and theater for children. Favorites are The Howard Gardner School, Traveling Player’s Ensemble and the Mount Vernon Unitarian Church.